Gross Profit (TTM) Chart

Historical Gross Profit (TTM) Data

View and export this data back to 2016. Start Trial.
Date Value
September 30, 2026 1.605M
June 30, 2026 1.098M
March 31, 2026 0.6642M
December 31, 2025 0.359M
September 30, 2025 -3.122M
June 30, 2025 -3.844M
March 31, 2025 -4.530M
December 31, 2024 -4.800M
September 30, 2024 -1.790M
June 30, 2024 -1.689M
March 31, 2024 -1.199M
December 31, 2023 -1.064M
September 30, 2023 -0.8652M
June 30, 2023 -0.6298M
March 31, 2023 -0.429M
December 31, 2022 -0.3074M
September 30, 2022 9.698M
June 30, 2022 9.708M
March 31, 2022 10.94M
Date Value
December 31, 2021 12.18M
September 30, 2021 3.428M
June 30, 2021 3.479M
March 31, 2021 2.300M
December 31, 2020 1.105M
September 30, 2020 -0.0785M
June 30, 2020 -0.0596M
March 31, 2020 -0.041M
December 31, 2019 -0.0153M
September 30, 2019 -0.0108M
June 30, 2019 -0.0128M
March 31, 2019 -0.0164M
December 31, 2018 -0.0191M
September 30, 2018 -0.0299M
June 30, 2018 -0.0316M
March 31, 2018 -0.0313M
December 31, 2017 -0.026M
March 31, 2017 -0.0129M
December 31, 2016 -0.0059M

Gross Profit Definition

Annual, Interim and Preliminary Items - Commercial, Other Financial Companies

Read full definition.

Gross Profit (TTM) Range, Past 5 Years

View Gross Profit (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit (TTM) Benchmarks

View Gross Profit (TTM) Benchmarks
Start Trial
EyePoint, Inc. -1.287M
ANI Pharmaceuticals, Inc. 553.08M
Corcept Therapeutics, Inc. 949.55M
Veru, Inc. -0.113M
Johnson & Johnson 67.20B